E-LIB Suche - Ergebnisse für: Chmura, Steven J

1

MMOD-06 IMPACT OF SYSTEMIC THERAPY TIMING AFTER STEREOTACTI..:

Qazi, Jamiluddin ; Carpenter, David ; Broadwater, Gloria...
Neuro-Oncology Advances. 6 (2024) Supplement_1 - p. i16-i16 , 2024

Link: https://doi.org/10.1093/..

2

A multi-institutional phase I study of acetazolamide with t..:

Driscoll, Riley K ; Lyne, Sean B ; Voce, David J...
Neuro-Oncology Advances. 6 (2024) 1 - p. , 2024

Link: https://doi.org/10.1093/..

3

RADT-04 IMPROVED SURVIVAL IN PATIENTS WITH RADIONECROSIS VS..:

Leng, Jim ; Arshad, Muzamil ; Carpenter, David...
Neuro-Oncology Advances. 6 (2024) Supplement_1 - p. i30-i30 , 2024

Link: https://doi.org/10.1093/..

4

Combined Stereotactic Body Radiation Therapy and Immune Che..:

Lynch, Connor ; Korpics, Mark C. ; Katipally, Rohan R....
International Journal of Radiation Oncology*Biology*Physics. 118 (2024) 5 - p. 1519-1530 , 2024

Link: https://doi.org/10.1016/..

5

Determinants of Symptomatic Intracranial Progression After ..:

Leng, Jim X. ; Carpenter, David J. ; Huang, Christina...
Advances in Radiation Oncology. 9 (2024) 6 - p. 101475 , 2024

Link: https://doi.org/10.1016/..

6

LMAP-08 MULTI-INSTITUTIONAL CLINICAL OUTCOMES FOLLOWING STE..:

Huang, Christina ; Leng, Jim ; Qazi, Jamiluddin...
Neuro-Oncology Advances. 5 (2023) Supplement_3 - p. iii10-iii11 , 2023

Link: https://doi.org/10.1093/..

7

Partial tumor irradiation plus pembrolizumab in treating la..:

Korpics, Mark C. ; Onderdonk, Benjamin E. ; Dadey, Rebekah E....
Journal of Clinical Investigation. 133 (2023) 10 - p. , 2023

Link: https://doi.org/10.1172/..

8

YTHDF2 inhibition potentiates radiotherapy antitumor effica..:

Wang, Liangliang ; Dou, Xiaoyang ; Chen, Shijie...
Cancer Cell. 41 (2023) 7 - p. 1294-1308.e8 , 2023

Link: https://doi.org/10.1016/..

9

Epitranscriptional regulation of TGF-β pseudoreceptor BAMBI..:

Wang, Liangliang ; Si, Wei ; Yu, Xianbin...
Journal of Clinical Investigation. 133 (2023) 24 - p. , 2023

Link: https://doi.org/10.1172/..

10

CLRM-01 DETERMINANTS OF SYMPTOMATIC INTRACRANIAL PROGRESSIO..:

Leng, Jim ; Huang, Christina ; Qazi, Jamiluddin...
Neuro-Oncology Advances. 5 (2023) Supplement_3 - p. iii7-iii7 , 2023

Link: https://doi.org/10.1093/..

11

Radiation dose, schedule, and novel systemic targets for ra..:

Karapetyan, Lilit ; Iheagwara, Uzoma K ; Olson, Adam C...
JNCI: Journal of the National Cancer Institute. 115 (2023) 11 - p. 1278-1293 , 2023

Link: https://doi.org/10.1093/..

12

Should We Target OligometastaticEGFR-Mutated Non-Small Cell..:

Milano, Michael T ; Salama, Joseph K ; Chmura, Steven J
JNCI: Journal of the National Cancer Institute. 115 (2022) 6 - p. 605-607 , 2022

Link: https://doi.org/10.1093/..

13

Prognostic Model for Intracranial Progression after Stereot..:

Carpenter, David J. ; Natarajan, Brahma ; Arshad, Muzamil...
Cancers. 14 (2022) 21 - p. 5186 , 2022

Link: https://doi.org/10.3390/..

14

Transposon Mutagenesis Reveals RBMS3 Silencing as a Promote..:

Vaishnavi, Aria ; Juan, Joseph ; Jacob, Maebh...
Cancer Research. 82 (2022) 22 - p. 4261-4273 , 2022

Link: https://doi.org/10.1158/..

15

From Idea to Clinical Practice: A Brief History of Oligomet..:

Tran, Phuoc T. ; Sutera, Philip ; Phillips, Ryan M...
International Journal of Radiation Oncology*Biology*Physics. 114 (2022) 4 - p. 576-580 , 2022

Link: https://doi.org/10.1016/..